Why Is ASCENTAGE PHARMA GRO ADR (AAPG) Stock Moving Today?
ASCENTAGE PHARMA GRO ADR (AAPG) is drawing unusual attention today.
Ascentage Pharma Group International (AAPG) shares fell 6.70% to $13.64 on Monday, following the announcement that the company’s drug lisaftoclax was added to China’s 2026 National Reimbursement Drug List. The stock also saw the successful renewal of coverage for olverembatinib, with both changes effective January 1, 2027.
What Happened
Ascentage Pharma announced that lisaftoclax was included in China’s 2026 National Reimbursement Drug List for the first time. The company also confirmed the successful renewal of coverage for olverembatinib in the same list. These regulatory updates expand market access for the company’s key products in China, its primary market. The news was reported across multiple financial outlets within the last 36 hours, highlighting the strategic importance of these listings for the company’s commercial pipeline.
What The Data Shows
The stock opened at $14.00, a 4.2% gap down from the prior close of $14.62. The session high was $14.00 at 7:00 AM ET, while the session low reached $13.60 at 9:30 AM ET. Volume so far is 0.0M shares, which is 0.5x the 3-month daily average. Fundamentals show a market cap of $1.3B with the company remaining unprofitable, posting a trailing twelve-month EPS of -0.58. Revenue grew 64.5% over the trailing twelve months, but the net margin stands at -228.5%. The stock has a beta of 0.77 and a 52-week range of $13.46 to $34.50. Over the last 8 sessions, the stock moved -3.0% from $15.07 to $14.62. The 52-week tape recorded one fresh 52-week high and one fresh 52-week low on November 16, 2026.
What To Watch
Ascentage Pharma is scheduled to present clinical and preclinical data at the 68th ASH Annual Meeting. The company will present data on four innovative drug candidates, including first clinical results for APG-5918. Additionally, the company is set to participate in two upcoming investor conferences in London.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
AAPG by the numbers
The headlines behind the move
No wire coverage in the public window yet. Open the live terminal for the real-time tape.
More moves explained today
- Why is ACCV down today (-18.94%)
- Why is SVRA down today (-17.95%)
- Why is APLD down today (-17.45%)
- Why is AAOI down today (-16.14%)
- Why is CLS down today (-15.03%)
- Why is WOLF down today (-14.70%)
More on AAPG: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier AAPG move explainers: 2026-11-16